Cannabinoids throw up a conundrum

British Journal of Pharmacology

Volumn 137, Issue 5, 2002, Pages 575-577

  Townsend IV, DeWayne ^a   Thayer, Stanley A ^a   Brown, David R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

9 tetrahydrocannabinol; 5 HT 3 receptor; Allosteric interaction; Emesis; Endocannabinoids; Ionotropic modulation; Neuronal signalling; Pain

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; DRONABINOL; ION CHANNEL; RECEPTOR SUBUNIT; RIMONABANT; SEROTONIN; SEROTONIN 3 RECEPTOR; VANILLOID RECEPTOR;

ALLOSTERISM; ANALGESIC ACTIVITY; ANTIEMETIC ACTIVITY; BINDING SITE; DEPOLARIZATION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; INOTROPISM; ION CONDUCTANCE; KNOCKOUT MOUSE; NAUSEA; NODOSE GANGLION; NONHUMAN; NOTE; PAIN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; VOMITING;

CANNABINOIDS; HUMANS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; TETRAHYDROCANNABINOL;

EID: 0036849058     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704913     Document Type: Note

References (10)

1. 3A receptors: Probable involvement of an allosteric modulatory site. Brit. J. Pharmacol., (in press).
2. Belelli, D., Pistis, M., Peters, J.A. & Lambert, J.J. (1999). The interaction of general anaesthetics and neurosteroids with GABA(A)and glycine receptors. Neurochem. Int., 34, 447-452.
3. Bullock, A.E., Clark, A.L., Grady, S.R., Robinson, S.F., Slobe, B.S., Marks, M.J. & Collins, A.C. (1997). Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J. Neurochem., 68, 2412-2423.
4. 3 receptors in rat nodose ganglion neurons. J. Neurophysiol., 73, 907-910.
5. 2 receptors. Mol. Pharmacol., 48, 443-450.
6. Hornby, P.J. (2001). Central neurocircuitry associated with emesis. Am. J. Med., 111 (Suppl 8A): 106S-112S.
7. Kunos, G., Jarai, Z., Batkai, S., Goparaju, S.K., Ishac, E.J., Liu, J., Wang, L. & Wagner, J.A. (2000). Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids., 108, 159-168.
8. Martin, B.R. (2002). Identification of the endogenous cannabinoid system through integrative pharmacological approaches. J. Pharmacol. Exp. Ther., 301, 790-796.
9. Smart, D., Gunthorpe, M.J., Jerman, J.C., Nasir, S., Gray, J., Muir, A.I., Chambers, J.K., Randall, A.D. & Davis, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Brit. J. Pharmacol., 129, 227-230.
10. 2 cannabinoid receptor-independent mechanism. J. Neurosci., 22, 4720-4727.